Skip to main content
Signal8

Poradosu Enrique

SEC insider (Form 3/4/5 filer). CIK 0001898147. Chief Science & Business Off at Nuvectis Pharma, Inc. (NVCT). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 6, 2026. Located in FORT LEE, NJ.

Companies Poradosu Enrique has filed insider reports for

  • Nuvectis Pharma, Inc. (NVCT): Officer, Chief Science & Business Off
Poradosu Enrique profile photo

Poradosu Enrique

CIK: 0001898147

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nuvectis Pharma, Inc. logo
NVCT

Nuvectis Pharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Nuvectis Pharma, Inc. logo
    NVCT

    Nuvectis Pharma, Inc.

    Jan 6, 2026
    Award
    Direct
    150K shares-
  • Nuvectis Pharma, Inc. logo
    NVCT

    Nuvectis Pharma, Inc.

    Jan 2, 2025
    Award
    Direct
    150K shares-
  • Nuvectis Pharma, Inc. logo
    NVCT

    Nuvectis Pharma, Inc.

    Nov 19, 2024
    Purchase
    Direct
    2K shares at avg. $4.99$10K

1-3 of 3